• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛脱氢酶 1A1 和 1A3 同工酶-在癌症中的激活和调节机制。

Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.

机构信息

Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, Dubravska cesta 9, 84505 Bratislava, Slovakia.

Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, Dubravska cesta 9, 84505 Bratislava, Slovakia.

出版信息

Cell Signal. 2021 Nov;87:110120. doi: 10.1016/j.cellsig.2021.110120. Epub 2021 Aug 21.

DOI:10.1016/j.cellsig.2021.110120
PMID:34428540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8505796/
Abstract

In some types of human cancer, aldehyde dehydrogenases represent stemness markers and their expression is associated with advanced disease stages and poor prognosis. Although several biological functions are mediated by their product Retinoid acid, the molecular mechanism is tissue-dependent and only partially understood. In this review, we summarize the current knowledge about the role of ALDH in solid tumours, especially ALDH1A1 and ALDH1A3 isoforms, regarding the molecular mechanism of their transcription and regulation, and their crosstalk with main molecular pathways resulting in the excessive proliferation, chemoresistance, stem cells properties and invasiveness. The recent knowledge of the regulatory effect of lnRNA on ALDH1A1 and ALDH1A3 is discussed too.

摘要

在某些类型的人类癌症中,醛脱氢酶代表干细胞标志物,其表达与晚期疾病阶段和预后不良相关。尽管它们的产物视黄酸介导了几种生物学功能,但分子机制是组织依赖性的,并且仅部分了解。在这篇综述中,我们总结了目前关于 ALDH 在实体瘤中的作用的知识,特别是 ALDH1A1 和 ALDH1A3 同工型,涉及它们的转录和调节的分子机制,以及它们与主要分子途径的相互作用,导致过度增殖、化疗耐药、干细胞特性和侵袭性。还讨论了 lncRNA 对 ALDH1A1 和 ALDH1A3 的调节作用的最新知识。

相似文献

1
Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.醛脱氢酶 1A1 和 1A3 同工酶-在癌症中的激活和调节机制。
Cell Signal. 2021 Nov;87:110120. doi: 10.1016/j.cellsig.2021.110120. Epub 2021 Aug 21.
2
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.醛脱氢酶和雌激素受体界定了正常人类乳腺上皮细胞分化的层次结构。
Breast Cancer Res. 2014 May 27;16(3):R52. doi: 10.1186/bcr3663.
3
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.醛脱氢酶活性在神经母细胞瘤的侵袭性表型中起关键作用。
BMC Cancer. 2016 Oct 10;16(1):781. doi: 10.1186/s12885-016-2820-1.
4
Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis.醛脱氢酶 1A(ALDH1A)亚家族成员的结构和动力学特征,在维甲酸生物合成中作为癌症干细胞标志物的活性。
Arch Biochem Biophys. 2020 Mar 15;681:108256. doi: 10.1016/j.abb.2020.108256. Epub 2020 Jan 7.
5
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.ALDH1A1 通过与 AR 和 RAR 依赖性转录的相互作用,驱动前列腺癌转移和放射抵抗。
Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024.
6
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.双重抑制醛脱氢酶 1 和 3 促进谷胱甘肽氧化还原系统的功能变化,并增强非小细胞肺癌的化疗敏感性。
Oncogene. 2020 Mar;39(13):2756-2771. doi: 10.1038/s41388-020-1184-9. Epub 2020 Feb 3.
7
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.ALDH1A1 和 ALDH1A3 在介导人乳腺癌细胞转移行为和治疗抵抗中的差异功能作用。
Int J Mol Sci. 2017 Sep 22;18(10):2039. doi: 10.3390/ijms18102039.
8
Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?乙醛脱氢酶 1A1:女性代谢的朋友还是敌人?
Nutrients. 2014 Mar 3;6(3):950-73. doi: 10.3390/nu6030950.
9
Importance of ALDH1A enzymes in determining human testicular retinoic acid concentrations.醛脱氢酶1A(ALDH1A)家族酶在决定人体睾丸视黄酸浓度中的重要性。
J Lipid Res. 2015 Feb;56(2):342-57. doi: 10.1194/jlr.M054718. Epub 2014 Dec 11.
10
Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.1A 亚家族醛脱氢酶抑制剂作为潜在的抗癌药物:动力学特征及其对人癌细胞的影响。
Chem Biol Interact. 2019 Jun 1;306:123-130. doi: 10.1016/j.cbi.2019.04.004. Epub 2019 Apr 5.

引用本文的文献

1
Protein Marker-Dependent Drug Discovery Targeting Breast Cancer Stem Cells.基于蛋白质标志物的乳腺癌干细胞靶向药物发现
Int J Mol Sci. 2025 Aug 17;26(16):7935. doi: 10.3390/ijms26167935.
2
The Role of the ALDH Family in Predicting Prognosis and Therapy Response in Pancreatic Cancer.醛脱氢酶家族在预测胰腺癌预后及治疗反应中的作用
Biomedicines. 2025 Aug 19;13(8):2018. doi: 10.3390/biomedicines13082018.
3
Multiple roles of ALDH1 in health and disease.醛脱氢酶1(ALDH1)在健康与疾病中的多重作用。

本文引用的文献

1
Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells.ALDH1A1-NEK-2轴与卵巢癌细胞顺铂耐药性的关联
Heliyon. 2020 Nov 12;6(11):e05442. doi: 10.1016/j.heliyon.2020.e05442. eCollection 2020 Nov.
2
ALDH Population Is Regulated by the AKT/β-Catenin Pathway in a Cervical Cancer Model.在宫颈癌模型中,醛脱氢酶(ALDH)群体受AKT/β-连环蛋白信号通路调控。
Front Oncol. 2020 Jul 17;10:1039. doi: 10.3389/fonc.2020.01039. eCollection 2020.
3
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs.
Front Physiol. 2025 Jul 10;16:1627164. doi: 10.3389/fphys.2025.1627164. eCollection 2025.
4
Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.异质性蛋白质动力学与线粒体活性、葡萄糖转运蛋白及醛脱氢酶癌症干细胞特性相关。
BMC Cancer. 2025 Jul 1;25(1):1085. doi: 10.1186/s12885-025-14460-x.
5
Expression of ALDH1 isotypes and its potential as a prognostic and diagnostic marker in patients with muscle invasive bladder cancer.醛脱氢酶1(ALDH1)亚型在肌层浸润性膀胱癌患者中的表达及其作为预后和诊断标志物的潜力。
Sci Rep. 2025 Jul 2;15(1):22599. doi: 10.1038/s41598-024-82460-1.
6
Diethyldithiocarbamate-CuO nanocomplex induced mitochondrial and telomerase dysfunction in non-small cell lung cancer.二乙基二硫代氨基甲酸盐-氧化铜纳米复合物诱导非小细胞肺癌中的线粒体和端粒酶功能障碍。
Nanomedicine (Lond). 2025 Jun;20(11):1267-1280. doi: 10.1080/17435889.2025.2502321. Epub 2025 May 16.
7
SYT7 accelerates nasopharyngeal carcinoma progression via ALDH1A3-mediated STAT3 signaling activation.SYT7通过醛脱氢酶1A3(ALDH1A3)介导的信号转导和转录激活因子3(STAT3)信号激活促进鼻咽癌进展。
Oncogenesis. 2025 May 9;14(1):16. doi: 10.1038/s41389-025-00558-1.
8
ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review).乳腺癌中的乙醛脱氢酶1A1:克服治疗耐药性的潜在靶点(综述)
Oncol Lett. 2025 Mar 4;29(5):213. doi: 10.3892/ol.2025.14959. eCollection 2025 May.
9
Development and synthesis of diffractaic acid analogs as potent inhibitors of colorectal cancer stem cell traits.作为结直肠癌干细胞特性有效抑制剂的衍射酸类似物的开发与合成。
Sci Rep. 2025 Feb 25;15(1):6695. doi: 10.1038/s41598-025-90552-9.
10
Ferroptosis- and stemness inhibition-mediated therapeutic potency of ferrous oxide nanoparticles-diethyldithiocarbamate using a co-spheroid 3D model of pancreatic cancer.使用胰腺癌共球体三维模型研究氧化亚铁纳米颗粒-二乙基二硫代氨基甲酸盐介导的铁死亡和干性抑制的治疗效果
J Gastroenterol. 2025 May;60(5):641-657. doi: 10.1007/s00535-025-02213-3. Epub 2025 Jan 31.
缺失的长链非编码 RNA:通过抑制长链非编码 RNA 靶向三阴性乳腺癌和癌症干细胞的潜力。
Cells. 2020 Mar 20;9(3):763. doi: 10.3390/cells9030763.
4
The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.长链非编码 RNA DANCR 通过 EZH2 依赖性抑制 SOCS3 转录调节乳腺癌细胞的炎症表型并促进乳腺癌进展。
Mol Oncol. 2020 Feb;14(2):309-328. doi: 10.1002/1878-0261.12622. Epub 2020 Jan 10.
5
Small molecule and peptide-based CXCR4 modulators as therapeutic agents. A patent review for the period from 2010 to 2018.基于小分子和肽的 CXCR4 调节剂作为治疗剂。2010 年至 2018 年期间的专利审查。
Expert Opin Ther Pat. 2020 Feb;30(2):87-101. doi: 10.1080/13543776.2020.1707186. Epub 2020 Jan 7.
6
Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells up-regulation of MEST through NF-κB1.长链非编码 RNA LINC00284 敲低通过 NF-κB1 上调 MEST 减少卵巢癌细胞中的血管生成。
FASEB J. 2019 Nov;33(11):12047-12059. doi: 10.1096/fj.201900101RR. Epub 2019 Oct 1.
7
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.ALDH1A3 调控的长非编码 RNA NRAD1 是三阴性乳腺癌和癌症干细胞的潜在新靶点。
Cell Death Differ. 2020 Jan;27(1):363-378. doi: 10.1038/s41418-019-0362-1. Epub 2019 Jun 13.
8
Nrf2 in cancers: A double-edged sword.Nrf2 在癌症中的作用:一把双刃剑。
Cancer Med. 2019 May;8(5):2252-2267. doi: 10.1002/cam4.2101. Epub 2019 Mar 30.
9
Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells.醛脱氢酶:不仅仅是标志物,更是干细胞的功能调节因子。
Stem Cells Int. 2019 Jan 13;2019:3904645. doi: 10.1155/2019/3904645. eCollection 2019.
10
Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer.HOXA4、HOXA9 和 HOXD10 的基因表达特征揭示了结肠癌中转录调控网络的改变。
J Cell Physiol. 2019 Aug;234(8):13042-13056. doi: 10.1002/jcp.27975. Epub 2018 Dec 14.